Advertisement

Psychopharmacology

, Volume 233, Issue 18, pp 3353–3360 | Cite as

Effect of combined oral doses of Δ9-tetrahydrocannabinol (THC) and cannabidiolic acid (CBDA) on acute and anticipatory nausea in rat models

  • Erin M. Rock
  • Cassidy Connolly
  • Cheryl L. Limebeer
  • Linda A. ParkerEmail author
Original Investigation

Abstract

Rationale

The purpose of this study was to evaluate the potential of oral combined cannabis constituents to reduce nausea.

Objective

The objective of this study was to determine the effect of combining subthreshold oral doses of Δ9-tetrahydrocannabinol (THC) and cannabidiolic acid (CBDA) on acute and anticipatory nausea in rat models of conditioned gaping.

Material and methods

The potential of intragastric (i.g.) administration of THC, CBDA, or combined doses, to interfere with acute nausea-induced conditioned gaping (acute nausea) or the expression of contextually elicited conditioned gaping (anticipatory nausea), was evaluated.

Results

For acute nausea, i.g. administration of subthreshold doses of THC (0.5 and 1 mg/kg) or CBDA (0.5 and 1 μg/kg) significantly suppressed acute nausea-induced gaping, whereas higher individual doses of both THC and CBDA were maximally effective. Combined i.g. administration of higher doses of THC and CBDA (2.5 mg/kg THC-2.5 μg/kg CBDA; 10 mg/kg THC-10 μg/kg CBDA; 20 mg/kg THC-20 μg/kg CBDA) also enhanced positive hedonic reactions elicited by saccharin solution during conditioning. For anticipatory nausea, combined subthreshold i.g. doses of THC (0.1 mg/kg) and CBDA (0.1 μg/kg) suppressed contextually elicited conditioned gaping. When administered i.g., THC was effective on its own at doses ranging from 1 to 10 mg/kg, but CBDA was only effective at 10 μg/kg. THC alone was equally effective by intraperitoneal (i.p.) and i.g. administration, whereas CBDA alone was more effective by i.p. administration (Rock et al. in Psychopharmacol (Berl) 232:4445–4454, 2015) than by i.g. administration.

Conclusions

Oral administration of subthreshold doses of THC and CBDA may be an effective new treatment for acute nausea and anticipatory nausea and appetite enhancement in chemotherapy patients.

Keywords

CBDA THC Oral administration Acute nausea Anticipatory nausea Conditioned gaping Hedonic reactions Locomotor activity 

Notes

Acknowledgments

This work was supported by a Natural Sciences and Engineering Research Council of Canada (NSERC) Collaborative Research and Development Grant (CRDPJ 476416–14) to LAP in partnership with Prairie Plant Systems Inc, as well as grants to LAP from NSERC (92056) and Canadian Institute of Health Research (137122).

References

  1. Bolognini D, Rock EM, Cluny NL, Cascio MG, Limebeer CL, Duncan M, Stott CG, Javid FA, Parker LA, Pertwee RG (2013) Cannabidiolic acid prevents vomiting in Suncus murinus and nausea-induced behaviour in rats by enhancing 5-HT1A receptor activation. Br J Pharmacol 168:1456–70. doi: 10.1111/bph.12043 CrossRefPubMedPubMedCentralGoogle Scholar
  2. Grill HJ, Norgren R (1978) The taste reactivity test. I. Mimetic responses to gustatory stimuli in neurologically normal rats. Brain Res 143:263–279CrossRefPubMedGoogle Scholar
  3. Hazekamp A, Ware MA, Muller-Vahl KR, Abrams D, Grotenhermen F (2013) The medicinal use of cannabis and cannabinoids--an international cross-sectional survey on administration forms. J Psychoactive Drugs 45:199–210CrossRefPubMedGoogle Scholar
  4. Hesketh PJ, Van Belle S, Aapro M, Tattersall FD, Naylor RJ, Hargreaves R, Carides AD, Evans JK, Horgan KJ (2003) Differential involvement of neurotransmitters through the time course of cisplatin-induced emesis as revealed by therapy with specific receptor antagonists. Eur J Cancer 39:1074–1080CrossRefPubMedGoogle Scholar
  5. Hickok JT, Roscoe JA, Morrow GR, King DK, Atkins JN, Fitch TR (2003) Nausea and emesis remain significant problems of chemotherapy despite prophylaxis with 5-hydroxytryptamine-3 antiemetics. Cancer 97:2880–2886CrossRefPubMedGoogle Scholar
  6. Limebeer CL, Vemuri VK, Bedard H, Lang ST, Ossenkopp KP, Makriyannis A, Parker LA (2010) Inverse agonism of cannabinoid CB1 receptors potentiates LiCl-induced nausea in the conditioned gaping model in rats. Br J Pharmacol 161:336–349. doi: 10.1111/j.1476-5381.2010.00885.x CrossRefPubMedPubMedCentralGoogle Scholar
  7. Malik IA, Khan WA, Qazilbash M, Ata E, Butt A, Khan MA (1995) Clinical efficacy of lorazepam in prophylaxis of anticipatory, acute, and delayed nausea and vomiting induced by high doses of cisplatin. A prospective randomized trial. Am J Clin Oncol 18:170–175CrossRefPubMedGoogle Scholar
  8. Nesse RM, Carli T, Curtis GC, Kleinman PD (1980) Pretreatment nausea in cancer chemotherapy: a conditioned response? Psychosom Med 42:33–36CrossRefPubMedGoogle Scholar
  9. Parker LA (2014) Conditioned flavor avoidance and conditioned gaping: rat models of conditioned nausea. Eur J Pharmacol 722:122–33. doi: 10.1016/j.ejphar.2013.09.070 CrossRefPubMedGoogle Scholar
  10. Parker LA, Mechoulam R (2003) Cannabinoid agonists and antagonists modulate lithium-induced conditioned gaping in rats. Integr Physiol Behav Sci 38:133–45CrossRefPubMedGoogle Scholar
  11. Parker LA, Mechoulam R, Schlievert C, Abbott L, Fudge ML, Burton P (2003) Effects of cannabinoids on lithium-induced conditioned rejection reactions in a rat model of nausea. Psychopharmacol (Berl) 166(2):156–62Google Scholar
  12. Parker LA, Rock EM, Sticht MA, Wills KL, Limebeer CL (2015) Cannabinoids suppress acute and anticipatory nausea in pre-clinical rat models of conditioned gaping. Clin Pharmacol Ther 97:559–61. doi: 10.1002/cpt.98 CrossRefPubMedGoogle Scholar
  13. Razavi D, Delvaux N, Farvacques C, De Brier F, Van Heer C, Kaufman L, Derde MP, Beauduin M, Piccart M (1993) Prevention of adjustment disorders and anticipatory nausea secondary to adjuvant chemotherapy: a double-blind, placebo-controlled study assessing the usefulness of alprazolam. J Clin Oncol 11:1384–1390PubMedGoogle Scholar
  14. Rock EM, Limebeer CL, Mechoulam R, Piomelli D, Parker LA (2008) The effect of cannabidiol and URB597 on conditioned gaping (a model of nausea) elicited by a lithium-paired context in the rat. Psychopharmacol (Berl) 196:389–95CrossRefGoogle Scholar
  15. Rock EM, Bolognini D, Limebeer CL, Cascio MG, Anavi-Goffer S, Fletcher PJ, Mechoulam R, Pertwee RG, Parker LA (2012) Cannabidiol, a non-psychotropic component of cannabis, attenuates vomiting and nausea-like behaviour via indirect agonism of 5-HT(1A) somatodendritic autoreceptors in the dorsal raphe nucleus. Br J Pharmacol 165:2620–34. doi: 10.1111/j.1476-5381.2011.01621.x CrossRefPubMedPubMedCentralGoogle Scholar
  16. Rock EM, Kopstick RL, Limebeer CL, Parker LA (2013) Tetrahydrocannabinolic acid reduces nausea-induced conditioned gaping in rats and vomiting in Suncus murinus. Br J Pharmacol 170:641–8. doi: 10.1111/bph.12316 CrossRefPubMedPubMedCentralGoogle Scholar
  17. Rock EM, Limebeer CL, Navaratnam R, Sticht MA, Bonner N, Engeland K, Downey R, Morris H, Jackson M, Parker LA (2014a) A comparison of cannabidiolic acid with other treatments for anticipatory nausea using a rat model of contextually elicited conditioned gaping. Psychopharmacol (Berl) 231:3207–15. doi: 10.1007/s00213-014-3498-1 CrossRefGoogle Scholar
  18. Rock EM, Sticht MA, Parker LA (2014b) Effect of Phytocannabinoids on Nausea and Vomiting. In: Pertwee E (ed) Handbook of Cannabis. Oxford Scholarship, Oxford, pp 435–454CrossRefGoogle Scholar
  19. Rock EM, Limebeer CL, Parker LA (2015) Effect of combined doses of Δ(9)-tetrahydrocannabinol THC) and cannabidiolic acid (CBDA) on acute and anticipatory nausea using rat (Sprague- Dawley) models of conditioned gaping. Psychopharmacol (Berl) 232:4445–54. doi: 10.1007/s00213-015-4080-1 CrossRefGoogle Scholar
  20. Thamm DH, Vail DM (2007) Aftershocks of cancer chemotherapy: managing adverse effects. J Am Anim Hosp Assoc 43:1–7. doi: 10.5326/43.6.toc CrossRefPubMedGoogle Scholar
  21. Tomiyasu H, Takahashi M, Fujino Y, Ohno K, Tsujimoto H (2010) Gastrointestinal and hematologic adverse events after administration of vincristine, cyclophosphamide, and doxorubicin in dogs with lymphoma that underwent a combination multidrug chemotherapy protocol. J Vet Med Sci 72:1391–1397CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2016

Authors and Affiliations

  • Erin M. Rock
    • 1
  • Cassidy Connolly
    • 1
  • Cheryl L. Limebeer
    • 1
  • Linda A. Parker
    • 1
    • 2
    Email author
  1. 1.Department of Psychology and Collaborative Neuroscience ProgramUniversity of GuelphGuelphCanada
  2. 2.Department of PsychologyUniversity of GuelphGuelphCanada

Personalised recommendations